Rosacea and its topical management.

Area of Science:

• Dermatology
• Dermatologic Surgery
• Dermatologic Procedures

Background:

• Rosacea is a common chronic inflammatory skin condition affecting the face.
• It presents with distinct subtypes: erythematotelangiectatic, papulopustular, phymatous, and ocular rosacea.
• Effective management requires a tailored approach based on subtype and symptom severity.

Purpose of the Study:

• To review current treatment modalities for rosacea.
• To highlight the importance of a classification system in guiding therapeutic decisions.
• To outline goals of therapy, focusing on symptom reduction and quality of life improvement.

Main Methods:

• Review of existing literature on rosacea treatments.
• Discussion of topical agents, systemic therapies, and procedural interventions.
• Emphasis on a subtype-specific classification system for treatment selection.

Main Results:

• A range of treatments are available, including topical (metronidazole, azelaic acid, sodium sulfacetamide-sulfur) and systemic agents.
• Laser and light-based therapies, as well as surgical procedures, are options for specific presentations.
• Second-line topical treatments include benzoyl peroxide, clindamycin, calcineurin inhibitors, and permethrin.

Conclusions:

• Therapeutic decisions for rosacea can be guided by a 4-subtype classification system.
• Treatment aims to decrease papules, pustules, erythema, and discomfort, thereby enhancing patient quality of life.
• A comprehensive approach integrating various treatment modalities is essential for optimal rosacea management.